ロード中...
An open-label study of sodium oxybate (Xyrem(®)) in spasmodic dysphonia
OBJECTIVE: Spasmodic dysphonia (SD) is a task-specific laryngeal dystonia that affects speech production. Co-occurring voice tremor (VT) often complicates the diagnosis and clinical management of SD. Treatment of SD and VT is largely limited to botulinum toxin injections into laryngeal musculature;...
保存先:
| 出版年: | Laryngoscope |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5415435/ https://ncbi.nlm.nih.gov/pubmed/27808415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lary.26381 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|